Phenotypic screening reveals a highly selective phthalimide-based compound with antileishmanial activity
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0012050 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Farnaz Zahedifard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery and Evaluation Unit, Department of Parasitology, Faculty of Science, Charles University in Prague, Biocev, Vestec, Czech Republic. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Leishmania, Leishmaniasis, Cutaneous, Leishmania infantum. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Ministry of Education, Youth and Sports, Science & Engineering Research Board (SERB), Ministerstvo Školství, Mládeže a Tělovýchovy.
Abstract (Originalsprache)
Pharmacophores such as hydroxyethylamine (HEA) and phthalimide (PHT) have been identified as potential synthons for the development of compounds against various parasitic infections. In order to further advance our progress, we conducted an experiment utilising a collection of PHT and HEA derivatives through phenotypic screening against a diverse set of protist parasites. This approach led to the identification of a number of compounds that exhibited significant effects on the survival of Entamoeba histolytica , Trypanosoma brucei , and multiple life-cycle stages of Leishmania spp . The Leishmania hits were pursued due to the pressing necessity to expand our repertoire of reliable, cost-effective, and efficient medications for the treatment of leishmaniases. Antileishmanials must possess the essential capability to efficiently penetrate the host cells and their compartments in the disease context, to effectively eliminate the intracellular parasite. Hence, we performed a study to assess the effectiveness of eradicating L . infantum intracellular amastigotes in a model of macrophage infection. Among eleven L . infantum growth inhibitors with low-micromolar potency, PHT-39, which carries a trifluoromethyl substitution, demonstrated the highest efficacy in the intramacrophage assay, with an EC50 of 1.2 +/- 3.2 μM. Cytotoxicity testing of PHT-39 in HepG2 cells indicated a promising selectivity of over 90-fold. A chemogenomic profiling approach was conducted using an orthology-based method to elucidate the mode of action of PHT-39. This genome-wide RNA interference library of T . brucei identified sensitivity determinants for PHT-39, which included a P-type ATPase that is crucial for the uptake of miltefosine and amphotericin, strongly indicating a shared route for cellular entry. Notwithstanding the favourable properties and demonstrated efficacy in the Plasmodium berghei infection model, PHT-39 was unable to eradicate L . major infection in a murine infection model of cutaneous leishmaniasis. Currently, PHT-39 is undergoing derivatization to optimize its pharmacological characteristics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Drug Discovery and Evaluation Unit, Department of Parasitology, Faculty of Science, Charles University in Prague, Biocev, Vestec, Czech Republic.
- H. G. Khorana Centre for Chemical Biology, Department of Chemistry, Hansraj College, University of Delhi, Delhi, India.
- Department of Chemistry, Deenbandhu Chhotu Ram, University of Science & Technology, Murthal, Sonepat Haryana, India.
- Department of Chemistry, Miranda House, University of Delhi, Delhi, India.
- Delhi School of Public Health, Institution of Eminence, University of Delhi, Delhi, India.
ORCID-Profile: Martin Zoltner
Förderung
- Czech Ministry of Education, Youth and Sports
- Science & Engineering Research Board (SERB)
- Ministerstvo Školství, Mládeže a Tělovýchovy
- Science and Engineering Research Board
Zitieren
APA
Zahedifard, F., Bansal, M., Sharma, N., Kumar, S., Shen, S., Singh, P., Rathi, B., & Zoltner, M. (2024). Phenotypic screening reveals a highly selective phthalimide-based compound with antileishmanial activity. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012050
Vancouver
Zahedifard F, Bansal M, Sharma N, Kumar S, Shen S, Singh P, et al. Phenotypic screening reveals a highly selective phthalimide-based compound with antileishmanial activity. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012050
BibTeX
@article{Zahedifard2024,
author = {Zahedifard, Farnaz and Bansal, Meenakshi and Sharma, Neha and Kumar, Sumit and Shen, Siqi and Singh, Priyamvada and Rathi, Brijesh and Zoltner, Martin},
title = {Phenotypic screening reveals a highly selective phthalimide-based compound with antileishmanial activity},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0012050}
}
EUVIMED